This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pandozi, C. Articles by Santini, M. Search for Related Content PubMed PubMed Citation Articles by Pandozi, C. Articles by Santini, M.

CLINICAL STUDY: ELECTROPHYSIOLOGY

Postcardioversion atrial electrophysiologic changes induced by oral verapamil in patients with persistent atrial fibrillation

^a Department of Cardiac Diseases, San Filippo Neri Hospital, Rome, Italy

Manuscript received August 20, 1999; revised manuscript received July 6, 2000, accepted August 18, 2000.

Reprint requests and correspondence: Dr. Claudio Pandozi, Via Madonna di Fatima 24, 00147 Rome, Italy
m.santini{at}rmnet.it

OBJECTIVES

The aim of our study was to verify the effect of oral administration of verapamil on atrial electrophysiologic characteristics after cardioversion of persistent atrial fibrillation (AF) in humans.

BACKGROUND

Discordant findings have been reported regarding the efficacy of verapamil in preventing the electrical remodeling induced by AF.

METHODS

We determined the effective refractory periods (ERPs) at five pacing cycle lengths (300 to 700 ms) and in five right atrial sites after internal cardioversion of persistent AF (mean duration 238.1 ± 305.9 days) in 19 patients. Nine patients received oral verapamil (240 mg/day) starting four weeks before the electrophysiologic study, whereas the other 10 patients were in pharmacologic washout.

RESULTS

The mean ERPs were 202.0 ± 22.7 ms in the washout group and 189.3 ± 18.5 ms in the verapamil group (p < 0.0001). The degree of adaptation of refractoriness to rate was similar in the two groups (mean slope value in the washout group and verapamil group: 0.07 ± 0.03 and 0.08 ± 0.05, respectively), showing a normal or nearly normal adaptation to rate in the majority of the paced sites in both groups. The mean ERP was slightly longer in the septum than in the lateral wall and in the roof, both in the washout and verapamil groups.

CONCLUSIONS

In patients with persistent AF, long-term administration of verapamil before internal cardioversion resulted in 1) shortening of atrial ERPs; 2) no change in refractoriness dispersion within the right atrium; and 3) no change in atrial ERP adaptation to rate.

Abbreviations and Acronyms   AF = atrial fibrillation   ERP = effective refractory period

This article has been cited by other articles:

				Y. Kurita, H. Mitamura, A. Shiroshita-Takeshita, A. Yamane, M. Ieda, O. Kinebuchi, T. Sato, S. Miyoshi, M. Hara, S. Takatsuki, et al. Daily oral verapamil before but not after rapid atrial excitation prevents electrical remodeling Cardiovasc Res, May 1, 2002; 54(2): 447 - 455. [Abstract] [Full Text] [PDF]

				C Pandozi and M Santini Update on atrial remodelling owing to rate. Does atrial fibrillation always 'beget' atrial fibrillation? Eur. Heart J., April 1, 2001; 22(7): 541 - 553. [PDF]